Join us at #EHA2026 Congress for a #CLL symposium with Priv.-Doz. Dr. med. Paula Cramer, Professor
George Follows, MD, PhD, and Jennifer Woyach, MD. Explore updated targeted treatment sequencing in
Stockholm on 6/13 & virtually on 6/25: bit.ly/Stockholm26-T@PeerView#HemOnc#MedEd
#Neuroendocrine carcinoma (NEC) care is advancing. Learn how emerging evidence around DLL3-directed therapies and DLL3/CD3 BiTEs may help shape precision-driven treatment strategies and improve patient outcomes: bit.ly/40m8aY9#Oncology#MedEd@Ja_Capdevila
Seeking support after head and neck cancer treatment?
Join the 2026 Head & Neck Cancer Survivorship Symposium on 7/18 in Boston or online. Hear from experts, gain practical insights for life after treatment, and connect with a community that understands your journey. Register: bit.ly/HNCSS26
Hosted by @hncalliance & @AHNSinfo#HeadAndNeckCancer#CancerSurvivorship
We're excited to present new findings at #EHA2026 this Friday, 12 June, at 18:45 CEST.
Our poster, “Operational Integration of T-Cell–Engaging Bispecific Antibodies in Community Hematology,” explores how educational interventions improved community clinician preparedness for integrating bispecific therapies into practice. Be sure to check out our additional publications at #EHA2026 on the role of education for improving personalized care for AML, treatment selection and sequencing in CLL, and trends in clinician preparedness for use of 1L therapy in mantle cell lymphoma.
Join us at our CLL symposium, presented in partnership with @HealthTree and supported by @EliLillyandCo, on 13 June: bit.ly/Stockholm26-T#CLL#HemOnc#MedEd
aHUS is a type of thrombotic microangiopathy (TMA), a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to blood vessels, which can lead to organ failure and death.
Learn more about TMAs ⬇️
#CART therapy is transforming #lymphoma care! Pharmacists play a critical role in education, care coordination, safety management, and post-treatment monitoring throughout the CAR-T journey. Watch this #MedEd activity today to learn more: bit.ly/4qLGdV3